SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (1371)12/5/1997 2:09:00 AM
From: james  Read Replies (1) | Respond to of 4676
 
MZ, <<p.s. Small correction: I-CAM iz ICAM-1.>>. Just to show HAME.

I give mAB a better chance. Because I have not read anything about the half-life of ICAM-1 protein (lazy), any data? If it's long, AS might not generate a bottle-neck. Which might hold for AS/mAB in all cases targeting extracellular proteins. Sorry for posting this kind of counter-opinion on ISIP thread.

thanks